Skip to searchSkip to main content
Uniprism Market Research

HEALTHCARE

Global DNA And Gene Cloning Services Market - Industry Trends and Forecast to 2032

Request Free Sample

​REPORT OVERVIEW

Global DNA And Gene Cloning Services Market, By Product Type (Gene Synthesis, Custom Cloning, Sub-cloning, Others), Company Size (Small, Mid-size, Large), Type of Gene (Standard Gene, Complex Gene, Others), Application (DNA Sequencing, Mutagenesis, Genotyping, Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.

Market Insights
The global DNA and gene cloning services market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.

DNA and gene cloning services include the replication of specific DNA segments or complete genes. This is accomplished by methods such as recombinant DNA technology, in which huge amounts of the required genetic material are produced by extracting, replicating, and inserting DNA into host organisms, typically bacteria. These services are essential for genetics, biotechnology, and medical research since they facilitate the creation of new drugs, gene therapies, and genetic engineering techniques. The DNA and gene cloning services market includes the provision of cloning techniques, tools, and technologies to the academic, pharmaceutical, and biotechnology industries. It addresses the rising need for precision medicine, tailored treatments, and cutting-edge agricultural solutions. It offers bespoke cloning services, vector design, gene synthesis, and DNA sequencing.

The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
  • Rising prevalence of genetic disorders and diseases.
  • Growing investment in R&D by biotech companies.
RESTRAINTS
  • High costs associated with DNA and gene cloning services.
  • Ethical concerns and regulatory challenges.
OPPORTUNITIES
  • Expansion into emerging markets.
  • Development of novel cloning techniques.
CHALLENGES
  • Stringent regulatory approvals and compliance.
  • Ethical and social acceptance issues.

​SEGMENTATION

  • Product Type
    • Gene Synthesis
    • Custom Cloning
    • Sub-cloning
    • Others
  • Company Size
    • Small
    • Mid-size
    • Large
  • Type of Gene
    • Standard Gene
    • Complex Gene
    • Others
  • Application
    • DNA Sequencing
    • Mutagenesis
    • Genotyping
    • Others
  • End-user
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • The Netherlands
    • Belgium
    • Turkey
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Malaysia
    • Australia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • Kingdom of Saudi Arabia
    • South Africa
    • U.A.E.
    • Egypt
    • Rest of Middle East and Africa

​KEY MARKET PLAYERS

  • Bio-Techne
  • Charles River Laboratories
  • Eurofins Scientific
  • GenScript
  • Danaher Corporation
  • Syngene International Limited
  • Twist Bioscience
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Curia Global, Inc.

​Table OF CONTENTS

  • SECTION 1 - INTRODUCTION
  • 1.1 Taxonomy
  • 1.2 Market Overview
  • 1.3 Currency and Limitations
  •   1.3.1 Currency
  •   1.3.2 Limitations
  • 1.4 Key Competitors

  • SECTION 2 - RESEARCH METHODOLOGY
  • 2.1 Research Approach
  • 2.2 Data Collection and Validation
  •   2.2.1 Secondary Research
  •   2.2.2 Primary Research
  • 2.3 Market Assessment
  •   2.3.1 Market Size Estimation
  •   2.3.2 Bottom-up Approach
  •   2.3.3 Top-down Approach
  •   2.3.4 Growth Forecast
  • 2.4 Market Study Assumptions
  • 2.5 Data Sources

  • SECTION 3 - EXECUTIVE SUMMARY
  • 3.1 Global DNA And Gene Cloning Services Market, by Product Type
  • 3.2 Global DNA And Gene Cloning Services Market, by Company Size
  • 3.3 Global DNA And Gene Cloning Services Market, by Type of Gene
  • 3.4 Global DNA And Gene Cloning Services Market, by Application
  • 3.5 Global DNA And Gene Cloning Services Market, by End-user
  • 3.6 Global DNA And Gene Cloning Services Market, by Geography
  • 3.7 Market Position Grid

  • SECTION 4 - PREMIUM INSIGHTS
  • 4.1 Regulatory Framework
  •   4.1.1 Standards
  •   4.1.2 Regulatory Landscape
  • 4.2 Value Chain Analysis
  • 4.3 Supply Chain Analysis
  • 4.4 COVID-19 Impact
  • 4.5 Russia-Ukraine War Impact
  • 4.6 PORTER's Five Force Analysis
  • 4.7 PESTLE Analysis
  • 4.8 SWOT Analysis
  • 4.9 Go to Market Strategy
  • 4.10 Opportunity Orbit
  • 4.11 Multivariate Modelling
  • 4.12 Pricing Analysis

  • SECTION 5 - MARKET DYNAMICS
  • 5.1 Trends
  •   5.1.1 Growing adoption of CRISPR technology.
  •   5.1.2 Advancements in synthetic biology.
  •   5.1.3 Trend 3
  • 5.2 Drivers
  •   5.2.1 Rising prevalence of genetic disorders and diseases.
  •   5.2.2 Growing investment in R&D by biotech companies.
  •   5.2.3 Driver 3
  •   5.2.4 Driver 4
  • 5.3 Restraints
  •   5.3.1 High costs associated with DNA and gene cloning services.
  •   5.3.2 Ethical concerns and regulatory challenges.
  •   5.3.3 Restraint 3
  • 5.4 Opportunities
  •   5.4.1 Expansion into emerging markets.
  •   5.4.2 Development of novel cloning techniques.
  •   5.4.3 Opportunity 3
  •   5.4.4 Opportunity 4
  • 5.5 Challenges
  •   5.5.1 Stringent regulatory approvals and compliance.
  •   5.5.2 Ethical and social acceptance issues.
  •   5.5.3 Challenge 3

  • SECTION 6 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY PRODUCT TYPE
  • 6.1 Product Type Summary
  • 6.2 Market Attractive Index
  • 6.3 Global DNA And Gene Cloning Services Market, by Product Type (2019-2032)

  • SECTION 7 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY COMPANY SIZE
  • 7.1 Company Size Summary
  • 7.2 Market Attractive Index
  • 7.3 Global DNA And Gene Cloning Services Market, by Company Size (2019-2032)

  • SECTION 8 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY TYPE OF GENE
  • 8.1 Type of Gene Summary
  • 8.2 Market Attractive Index
  • 8.3 Global DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)

  • SECTION 9 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY APPLICATION
  • 9.1 Application Summary
  • 9.2 Market Attractive Index
  • 9.3 Global DNA And Gene Cloning Services Market, by Application (2019-2032)

  • SECTION 10 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY END-USER
  • 10.1 End-user Summary
  • 10.2 Market Attractive Index
  • 10.3 Global DNA And Gene Cloning Services Market, by End-user (2019-2032)

  • SECTION 11 - GLOBAL DNA AND GENE CLONING SERVICES MARKET, BY GEOGRAPHY
  • 11.1 Regional Summary
  • 11.2 Market Attractive Index
  • 11.3 Global DNA And Gene Cloning Services Market, by Geography (2019-2032)

  • SECTION 12 - NORTH AMERICA DNA AND GENE CLONING SERVICES MARKET
  • 12.1 North America Summary
  • 12.2 Market Attractive Index
  • 12.3 North America DNA And Gene Cloning Services Market, by Product Type (2019-2032)
  • 12.4 North America DNA And Gene Cloning Services Market, by Company Size (2019-2032)
  • 12.5 North America DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
  • 12.6 North America DNA And Gene Cloning Services Market, by Application (2019-2032)
  • 12.7 North America DNA And Gene Cloning Services Market, by End-user (2019-2032)
  • 12.8 North America DNA And Gene Cloning Services Market, by Country (2019-2032)
  •   12.8.1 U.S.
  •   12.8.2 Canada
  •   12.8.3 Mexico
  •   12.8.4 Rest of North America

  • SECTION 13 - EUROPE DNA AND GENE CLONING SERVICES MARKET
  • 13.1 Europe Summary
  • 13.2 Market Attractive Index
  • 13.3 Europe DNA And Gene Cloning Services Market, by Product Type (2019-2032)
  • 13.4 Europe DNA And Gene Cloning Services Market, by Company Size (2019-2032)
  • 13.5 Europe DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
  • 13.6 Europe DNA And Gene Cloning Services Market, by Application (2019-2032)
  • 13.7 Europe DNA And Gene Cloning Services Market, by End-user (2019-2032)
  • 13.8 Europe DNA And Gene Cloning Services Market, by Country (2019-2032)
  •   13.8.1 Germany
  •   13.8.2 U.K.
  •   13.8.3 France
  •   13.8.4 Italy
  •   13.8.5 Spain
  •   13.8.6 Russia
  •   13.8.7 The Netherlands
  •   13.8.8 Belgium
  •   13.8.9 Turkey
  •   13.8.10 Rest of Europe

  • SECTION 14 - ASIA-PACIFIC DNA AND GENE CLONING SERVICES MARKET
  • 14.1 Asia-Pacific Summary
  • 14.2 Market Attractive Index
  • 14.3 Asia-Pacific DNA And Gene Cloning Services Market, by Product Type (2019-2032)
  • 14.4 Asia-Pacific DNA And Gene Cloning Services Market, by Company Size (2019-2032)
  • 14.5 Asia-Pacific DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
  • 14.6 Asia-Pacific DNA And Gene Cloning Services Market, by Application (2019-2032)
  • 14.7 Asia-Pacific DNA And Gene Cloning Services Market, by End-user (2019-2032)
  • 14.8 Asia-Pacific DNA And Gene Cloning Services Market, by Country (2019-2032)
  •   14.8.1 China
  •   14.8.2 India
  •   14.8.3 Japan
  •   14.8.4 South Korea
  •   14.8.5 Singapore
  •   14.8.6 Malaysia
  •   14.8.7 Australia
  •   14.8.8 Thailand
  •   14.8.9 Philippines
  •   14.8.10 Rest of Asia-Pacific

  • SECTION 15 - SOUTH AMERICA DNA AND GENE CLONING SERVICES MARKET
  • 15.1 South America Summary
  • 15.2 Market Attractive Index
  • 15.3 South America DNA And Gene Cloning Services Market, by Product Type (2019-2032)
  • 15.4 South America DNA And Gene Cloning Services Market, by Company Size (2019-2032)
  • 15.5 South America DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
  • 15.6 South America DNA And Gene Cloning Services Market, by Application (2019-2032)
  • 15.7 South America DNA And Gene Cloning Services Market, by End-user (2019-2032)
  • 15.8 South America DNA And Gene Cloning Services Market, by Country (2019-2032)
  •   15.8.1 Brazil
  •   15.8.2 Argentina
  •   15.8.3 Chile
  •   15.8.4 Colombia
  •   15.8.5 Rest of South America

  • SECTION 16 - MIDDLE EAST AND AFRICA DNA AND GENE CLONING SERVICES MARKET
  • 16.1 Middle East and Africa Summary
  • 16.2 Market Attractive Index
  • 16.3 Middle East and Africa DNA And Gene Cloning Services Market, by Product Type (2019-2032)
  • 16.4 Middle East and Africa DNA And Gene Cloning Services Market, by Company Size (2019-2032)
  • 16.5 Middle East and Africa DNA And Gene Cloning Services Market, by Type of Gene (2019-2032)
  • 16.6 Middle East and Africa DNA And Gene Cloning Services Market, by Application (2019-2032)
  • 16.7 Middle East and Africa DNA And Gene Cloning Services Market, by End-user (2019-2032)
  • 16.8 Middle East and Africa DNA And Gene Cloning Services Market, by Country (2019-2032)
  •   16.8.1 Kingdom of Saudi Arabia
  •   16.8.2 South Africa
  •   16.8.3 U.A.E.
  •   16.8.4 Egypt
  •   16.8.5 Rest of Middle East and Africa

  • SECTION 17 - COMPANY SHARE ANALYSIS
  • 17.1 Global DNA And Gene Cloning Services Market, Company Share Analysis
  • 17.2 North America DNA And Gene Cloning Services Market, Company Share Analysis
  • 17.3 Europe DNA And Gene Cloning Services Market, Company Share Analysis
  • 17.4 Asia-Pacific DNA And Gene Cloning Services Market, Company Share Analysis

  • SECTION 18 - COMPANY PROFILES
  • 18.1 Bio-Techne
  •   18.1.1 Company Snapshot
  •   18.1.2 Financial Overview
  •   18.1.3 Product Portfolio
  •   18.1.4 Recent Developments
  • 18.2 Charles River Laboratories
  •   18.2.1 Company Snapshot
  •   18.2.2 Financial Overview
  •   18.2.3 Product Portfolio
  •   18.2.4 Recent Developments
  • 18.3 Eurofins Scientific
  •   18.3.1 Company Snapshot
  •   18.3.2 Financial Overview
  •   18.3.3 Product Portfolio
  •   18.3.4 Recent Developments
  • 18.4 GenScript
  •   18.4.1 Company Snapshot
  •   18.4.2 Financial Overview
  •   18.4.3 Product Portfolio
  •   18.4.4 Recent Developments
  • 18.5 Danaher Corporation
  •   18.5.1 Company Snapshot
  •   18.5.2 Financial Overview
  •   18.5.3 Product Portfolio
  •   18.5.4 Recent Developments
  • 18.6 Syngene International Limited
  •   18.6.1 Company Snapshot
  •   18.6.2 Financial Overview
  •   18.6.3 Product Portfolio
  •   18.6.4 Recent Developments
  • 18.7 Twist Bioscience
  •   18.7.1 Company Snapshot
  •   18.7.2 Financial Overview
  •   18.7.3 Product Portfolio
  •   18.7.4 Recent Developments
  • 18.8 Thermo Fisher Scientific Inc.
  •   18.8.1 Company Snapshot
  •   18.8.2 Financial Overview
  •   18.8.3 Product Portfolio
  •   18.8.4 Recent Developments
  • 18.9 Merck KGaA
  •   18.9.1 Company Snapshot
  •   18.9.2 Financial Overview
  •   18.9.3 Product Portfolio
  •   18.9.4 Recent Developments
  • 18.10 Curia Global, Inc.
  •   18.10.1 Company Snapshot
  •   18.10.2 Financial Overview
  •   18.10.3 Product Portfolio
  •   18.10.4 Recent Developments

  • SECTION 19 - RELATED REPORTS

  • SECTION 20 - DISCLAIMER

​RESEARCH METHODOLOGY

The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.

Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.

The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.

Below mention are few of the sources which we have considered while estimating the market size:
For instance,
  • Research articles published on Technium
  • Science and MDPI
  • Research publications by government approved associations and societies

Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING

The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.

MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.

Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.

We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT

Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.

Choose License Type

  • $3599
    $4799
    $5899
    $7499